tradingkey.logo
tradingkey.logo
Search

Mesa Laboratories Inc

MLAB
Add to Watchlist
93.100USD
-2.000-2.10%
Close 06/22, 16:00ETQuotes delayed by 15 min
514.37MMarket Cap
141.66P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-22
Previous score
7.33
Change
0
The current earnings forecast score of Mesa Laboratories Inc is 7.33, ranking 142 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 95.00, with a high of 115.00 and a low of 75.00.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
112.000
Target Price
+17.77%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Mesa Laboratories Inc
MLAB
3
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Mesa Laboratories Inc's expected revenue for the next quarter?

Mesa Laboratories Inc's expected revenue is 60.87M.

What is Mesa Laboratories Inc's price target?

Analysts forecast that Mesa Laboratories Inc's price target is USD 95.00, with the highest forecast at USD 115.00 and the lowest forecast at USD 75.00.

How have Mesa Laboratories IncMLAB's recent earnings per share performed?

The market expectation was USD -0.75, while Mesa Laboratories IncMLAB's earnings per share (EPS) for the previous quarter was USD 0.66. EPS for the next quarter is expected at USD 0.03.

What is the analyst rating for Mesa Laboratories Inc?

Based on the ratings of Mesa Laboratories Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI